| Literature DB >> 26997791 |
Tanuj Dada1, Shibal Bhartiya2, Nafees Begum Baig3.
Abstract
The problem of cataract management in the patients of glaucoma who have undergone fltering surgery is a challenging proposition for any surgeon, as the surgery can lead to several complications in the already compromised eye. As glaucoma requires lifelong management, the development of cataract is a significant concern because its treatment may lead to loss of intraocular pressure (IOP) control. This review aims to highlight the intra- and postoperative measures that may increase the chances of bleb survival following cataract surgery. How to cite this article: Dada T, Bhartiya S, Baig NB. Cataract Surgery in Eyes with Previous Glaucoma Surgery: Pearls and Pitfalls. J Current Glau Prac 2013;7(3):99-105.Entities:
Keywords: Cataract surgery; Filtering bleb; Glaucoma; Trabeculectomy.
Year: 2013 PMID: 26997791 PMCID: PMC4741148 DOI: 10.5005/jp-journals-10008-1145
Source DB: PubMed Journal: J Curr Glaucoma Pract ISSN: 0974-0333
Figs 1A and b(A) Preoperative photograph showing grade 5 nuclear sclerosis (LOCS) with bleb characteristics of H2E2V1S0 (Indiana Bleb Appearance Grading System), (B) postoperative photograph showing pseudophakia with raised, functional bleb
Figs 2A and b(A) Preoperative ASOCT showing a raised bleb with multiple cystic spaces suggestive of a functional bleb, (B) postoperative ASOCT showing a raised bleb with multiple cystic spaces suggestive of a functional bleb
Table 1: Bleb survival following cataract surgery
| Chen et al, 1998[ | 57/58 | 21.2 ± 19.1 | 17.6/24.5 phaco/ECCE | 10.5 ± 3.9 | 12.1 ± 5.1 | 74/64 phaco/ECCE | No additional surgery or medication | ||||||||
| Park et al, 1997[ | 40/0 | >5 | >12 | 13.5 | 13.3 ± 4.1 | 80 | IOP < 21, no additional surgery or medication | ||||||||
| Crichton et al, 2001[ | 69/0 | Mean 2.18 years | Mean 22.0 | 13.58 ± 3.98 | 14.39 | 77 | No additional surgery or medication | ||||||||
| Manoj et al, 2000[ | 21/0 | >6 | 15.09 | 13.86 ± 2.94 | 13.25 ± 2.49 | 100 | IOP < 21, no additional surgery or medication | ||||||||
| Casson et al, 2001[ | 28/0 | >3 | 24 | 14.4 ± 3.5 | 15.3 ± 3.1 | 86 | IOP < 21, no additional surgery or medication | ||||||||
| Rebolleda et al, 2002[ | 49/0 | >12 | 19.6 | 12.24 ± 4.68 | 13.81 | 65.3 | No additional surgery or medication | ||||||||
| Shingleton et al, 2003[ | 58 (26 scleral tunnel) | >4 | 12 | 11.8 ± 4.2 | 13.7 ± 4.6 | 98 | IOP < 21, no additional surgery or medication | ||||||||
| Derbolav et al, 2002[ | 48 | >3 | >12 | 13.3 | 14.9 | 67 | No additional surgery or medication | ||||||||
| Swamynathan et al, 2004[ | 29 | >3 | Mean 20.4 | 8.7 ± 4.5 | 11.8 ± 4.2 | 79 | No additional surgery or medication | ||||||||
| Salaga-Pylak et al, 2013[ | 50/0 | 19.9 ± 12.7 | 18 | 11.6 ± 3.8 | 15.3 ± 3.1 | 71 | No additional surgery or medication |